@article{25204,
  keywords = {Vaccination, Male, Malawi, leprosy, Infant, Newborn, Infant, Humans, Female, Evaluation Studies as Topic, Child, Preschool, Child, BCG Vaccine, Adult, Adolescent},
  author = {Fine PE and Ponnighaus J M and Maine N and Clarkson J A and Bliss L},
  title = {Protective efficacy of BCG against leprosy in Northern Malawi.},
  abstract = {<p>The effectiveness of a BCG vaccination programme in protecting against leprosy was assessed by case-control and cohort analyses of data from the Lepra Evaluation Project in Karonga District, Northern Malawi. Results indicate that BCG provides at least 50% protection against leprosy in this population and that protection is independent of age, sex, schooling status, or location within the project area. Agreement between these findings and those from a controlled trial in Uganda indicates that BCG is sufficiently effective against leprosy in East and Central Africa to be considered an important element of leprosy control in that region.</p>},
  year = {1986},
  journal = {Lancet},
  volume = {2},
  pages = {499-502},
  month = {1986 Aug 30},
  issn = {0140-6736},
  url = {http://www.med.mcgill.ca/epidemiology/Hanley/bios601/CaseControlStudies/FineEtAlBCGleprosy.pdf},
  language = {eng},
}